Clinical Trials
118 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
MK-3475-E90
Wellmarker Bio
HOLIPANC
University of Cologne
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
Chongqing Precision Biotech Co., Ltd
TWICE-IRI
Hôpital Franco-Britannique-Fondation Cognacq-Jay
Minnelide 101
Minneamrita Therapeutics LLC
Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors
Chinese PLA General Hospital
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
Zhongnan Hospital
MAP-01
Peking Union Medical College Hospital
COLT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
REGOMUNE
Institut Bergonié
The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.
Chang Gung Memorial Hospital
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
RECORD
Chinese PLA General Hospital
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Wellmarker Bio
FOOTPATH
Ludwig-Maximilians - University of Munich
LIVACOR
Fondazione Poliambulanza Istituto Ospedaliero
SPACE2
Weprom
Genomic Evolution of Metastasis in Gastric Cancer
University Medical Center Ho Chi Minh City (UMC)
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
TRANSGIST
Hospital Universitario Virgen de la Arrixaca
EPIC-1
Aalborg University Hospital
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
Scandion Oncology A/S
WUHIPEC01
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway
Norwegian University of Science and Technology
CTC_ctDNA
First Hospital of China Medical University
X7-7
University of Kansas Medical Center
Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer
Fudan University
Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
D1 Medical Technology (Shanghai) Co., Ltd, China
PATOC
Central Clinical Hospital RZD-Medicine, Russian Federation
An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer
Chinese PLA General Hospital
PIONEER
SpeciCare
SUNRISE-CRC
Amsterdam UMC, location VUmc
BATTLE
Sixth Affiliated Hospital, Sun Yat-sen University
REACHIN
Erasme University Hospital
A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
ChineseAMS
CoNoR
University of Manchester
Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer
Shanghai Chest Hospital
The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal Cancer
Sun Yat-sen University
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
Yonsei University
PAC-MAIN
Moscow Clinical Scientific Center
Study of Alofanib in Patients With Metastatic Gastric Cancer
Russian Pharmaceutical Technologies
IMPALA
Mologen AG
A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC
Chinese PLA General Hospital
Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin
Sixth Affiliated Hospital, Sun Yat-sen University
LyREMeNet
Hospices Civils de Lyon
Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)
West China Hospital
DOSE
Dong-A University Hospital
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
Korea University